Guard Therapeutics International AB (publ) (STO: GUARD)
Sweden flag Sweden · Delayed Price · Currency is SEK
29.20
+1.00 (3.55%)
Aug 30, 2024, 5:29 PM CET

GUARD Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Selling, General & Admin
9.199.158.825.9656.72
Upgrade
Research & Development
71.92105.77104.8175.3335.4237.56
Upgrade
Operating Expenses
81.11114.92113.6381.2840.4244.28
Upgrade
Operating Income
-81.11-114.92-113.63-81.28-40.42-44.28
Upgrade
Interest Expense
-0.01-0.01-0-0-0.01-0.87
Upgrade
Interest & Investment Income
2.442.20.140.02--
Upgrade
Currency Exchange Gain (Loss)
-0.15-0.590.65-0.770.14-
Upgrade
Other Non Operating Income (Expenses)
-000-0-0-
Upgrade
Pretax Income
-78.82-113.32-112.84-82.03-40.28-45.16
Upgrade
Net Income
-78.82-113.32-112.84-82.03-40.28-45.16
Upgrade
Net Income to Common
-78.82-113.32-112.84-82.03-40.28-45.16
Upgrade
Shares Outstanding (Basic)
10107432
Upgrade
Shares Outstanding (Diluted)
10107432
Upgrade
Shares Change (YoY)
16.90%42.77%57.95%34.53%63.36%475.62%
Upgrade
EPS (Basic)
-7.80-11.26-16.01-18.39-12.15-22.24
Upgrade
EPS (Diluted)
-7.80-11.26-16.01-18.39-12.15-22.24
Upgrade
Free Cash Flow
-80.89-116.05-102.14-77.59-37.96-60.28
Upgrade
Free Cash Flow Per Share
-8.00-11.53-14.49-17.39-11.45-29.69
Upgrade
EBITDA
-81.09-114.91-113.61-81.27-40.26-43.29
Upgrade
D&A For EBITDA
0.020.020.020.020.160.99
Upgrade
EBIT
-81.11-114.92-113.63-81.28-40.42-44.28
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.